Telesis Bio Inc. (TBIO) Share-based Payment Arrangement, Expense USD 2020 - 2024

Historical data

Taxonomy & unit: us-gaap: USD and USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Telesis Bio Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2024.
Telesis Bio Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $766 K, a 33.7% decline year-over-year.
Telesis Bio Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $3.57 M, a 20.3% decline year-over-year.
Telesis Bio Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.96 M, a 6.33% increase from 2022.
Telesis Bio Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.73 M, a 243% increase from 2021.
Telesis Bio Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1.09 M, a 2426% increase from 2020.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Quarterly Data (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2024	$3.57 M	$766 K	-$390 K	-33.7%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-10
Q4 2023	$3.96 M	$616 K	-$678 K	-52.4%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-29
Q3 2023	$4.64 M	$1.16 M	+$241 K	+26.3%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$4.4 M	$1.04 M	-$83 K	-7.42%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-11
Q1 2023	$4.48 M	$1.16 M	+$756 K	+189%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-10
Q4 2022	$3.73 M	$1.29 M	+$808 K	+166%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-29
Q3 2022	$2.92 M	$915 K	+$515 K	+129%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-13
Q2 2022	$2.4 M	$1.12 M	+$1.02 M	+1018%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-11
Q1 2022	$1.39 M	$400 K	+$300 K	+300%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-12
Q4 2021	$1.09 M	$486 K			Oct 1, 2021	Dec 31, 2021	10-K	2023-03-22
Q3 2021		$400 K	+$300 K	+300%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-09
Q2 2021		$100 K	+$90 K	+900%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-10
Q1 2021		$100 K			Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-11
Q3 2020		$100 K			Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-10
Q2 2020		$10 K			Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-11

* An asterisk sign (*) next to the value indicates that the value is likely invalid.